Introduction {#s1}
============

Loss of the sensory 'hair' cells from the cochlea, the mammalian hearing organ, as a consequence of exposure to ototoxic drugs, excessive noise or through ageing, results in permanent hearing loss. More than 40% of those aged over 50% and 70% of those over 70 have a clinically significant hearing loss (Action on Hearing Loss; [www.actiononhearingloss.org.uk/your-hearing/about-deafness-and-hearing-loss/statistics.aspx](https://www.actiononhearingloss.org.uk/your-hearing/about-deafness-and-hearing-loss/statistics.aspx)). Hearing loss has also been reported as a risk factor for dementia ([@bib36]). Loss of hair cells from the vestibular epithelia of the inner ear, results in balance dysfunction causing dizziness and vertigo, significantly under-appreciated disabling conditions. As with hearing loss, the prevalence of vestibular dysfunction increases with age. Dizziness is the most common reason for visits to the GP in those over 75% and 80% of unexplained falls in the elderly are attributable to vestibular dysfunction ([@bib1]; [@bib2]; [@bib14]; [@bib20]; [@bib44]). Regeneration of hair cells could potentially offer a therapeutic approach to amelioriate these conditions.

In the sensory epithelia of the inner ear in all vertebrates each hair cell is surrounded and separated from its neighbours by intervening supporting cells. Hair cells derive their name from the organised bundle of projections from the apical poles. They are mechanotransducers that convert motion into electrical signals. Supporting cells play a role in maintaining the physiological environment necessary for hair cell function and survival, and also repair the lesions in the epithelium when hair cells die. In non-mammalian vertebrates, hair cells lost from the auditory or vestibular sensory epithelia are replaced spontaneously by new ones ([@bib9]; [@bib46]). These nascent hair cells are derived from supporting cells. Initially, new hair cells arise from direct, non-mitotic transdifferentiation (phenotypic conversion) of supporting cells into hair cells ([@bib6]; [@bib50]). Other supporting cells re-enter the cell cycle, the daughter cells giving rise to hair and supporting cells ([@bib5]; [@bib6]; [@bib9]; [@bib46]). There is no regeneration in the adult mammalian auditory system. However, there is a limited capacity to regenerate hair cells in vivo in the mammalian vestibular system ([@bib16]; [@bib17]; [@bib37]; [@bib23]). These hair cells arise by direct phenotypic conversion of supporting cells ([@bib33]; [@bib35]). We recently reported the presence of cells bearing immature hair bundles in the vestibular system of elderly people ([@bib51]). This suggests that a capacity to regenerate hair cells may exist at a very low level throughout life in humans.

During development, supporting cells and hair cells are derived from the same homogeneous population of precursor cells following a terminal mitotic event ([@bib24]). The mosaic patterning of hair and supporting cells develops by lateral inhibition mediated by the Notch signalling pathway ([@bib27]). In cells differentiating as hair cells the basic helix-loop-helix transcription factor Atonal homolog 1 (Atoh1) is transiently expressed and has been shown to be necessary for sensory precursors to differentiate into hair cells ([@bib3]; [@bib24]; [@bib60]). The nascent hair cells express the Notch ligand Delta1 on their surface which activates the Notch receptor, a transmembrane protein, in adjacent neighbouring cells. The inhibitory activity of Notch prevents the adjacent cell following the same fate, so this cell will not become a hair cell but instead will be a supporting cell. Ligand binding to the Notch receptor triggers the extracellular cleavage of Notch by tumour necrosis factor alpha converting enzyme (TACE) ([@bib29]) and intracellular cleavage by γ-secretase ([@bib27]). This releases the Notch intracellular domain which enters the nucleus interacting with several transcription factors to suppress *Atoh1* expression thereby inhibiting differentiation as a hair cell and promoting HES/HEY expression, propelling those cells to become supporting cells.

*Atoh1* is expressed during hair cell regeneration in chick and zebrafish and several studies have shown that ectopic overexpression of Atoh1 in the organ of Corti or vestibular sensory epithelia of mammals is sufficient to induce generation of cells that express hair cell marker proteins ([@bib62]). These arise by direct transdifferentiation without an intervening mitotic event. Overexpressing *Atoh1* or using γ- secretase inhibitors, potentially offer means to induce supporting cells to become hair cells. Both these approaches have been applied to murine vestibular epithelia depleted of hair cells ([@bib35]; [@bib49]).

We have established a consortium of surgeons throughout the UK to harvest human vestibular epithelia from translabyrinthine operations for the removal of acoustic neuromas (vestibular schwannomas) ([@bib51]). Here we use the vestibular epithelium collected from such surgeries to examine the capacity of supporting cells to generate new hair cells in adult human inner ear tissue. We have used an adenoviral vector to deliver *ATOH1* (adV2- ATOH) to transduce cells in human sensory epithelia from which hair cells have been ablated with the ototoxic agent, gentamicin. We find that significant numbers of cells expressing hair cell markers can be generated. We have also exposed tissue to the γ- secretase inhibitor TAPI1 (TNFα protease inhibitor 1), a TACE inhibitor. Cells expressing hair cell marker proteins are also generated but in fewer numbers that with *ATOH1* transduction. However, neither protocol resulted in fully differentiated hair cells. Studies of gene expression following ATOH1 transduction by RNA sequencing confirmed that a significant cascade of downstream effectors is induced by this treatment. However, this induction falls short of complete hair cell conversion but highlights components that may be necessary in completing the conversion events.

Results {#s2}
=======

Utricles harvested from vestibular schwannoma surgeries were collected in medium and transported to the laboratory as previously described ([@bib51]). Tissue samples were examined and assessed before incubation in medium for ca. 18 hr prior to exposure to gentamicin or as a control in medium alone. Samples were used only when an intact epithelium was clearly visible under microscopic examination. Several harvested samples were not suitable for experimental use being damaged on excision or transfer. The age of the patients ranged between 17 and 81 (mean 50.6, median 51) but there was no selection or exclusion of samples on the basis of age or gender of the donor.

Untreated utricles {#s2-1}
------------------

In utricles fixed and processed immediately following harvesting, hair cells, labelled for myosin VIIa, a hair cell marker, were present across the entire epithelium ([Figure 1A](#fig1){ref-type="fig"}), but, as reported previously ([@bib51]), the density of hair cells varied and in some samples, particularly those from older individuals, there were very few. SEM showed the characteristic hair bundles of vestibular hair cells with stereocilia of graded height but there was considerable variability in the morphology of the bundles and the height of the longest stereocilia in each bundle ([Figure 1B](#fig1){ref-type="fig"}). Short microvilli covered the apical surfaces of supporting cells. Thin sections of untreated utricles revealed a bilayer of cells with rounded hair cell nuclei in the more apical region closer to the luminal surface, while the more irregularly shaped supporting cell nuclei were located close to the underlying basement membrane ([Figure 1C,D](#fig1){ref-type="fig"}). Hair cells survived in vitro in most untreated samples maintained in explant culture for 28 days although in some cultures incubated for this period, condensed, mis-shapen remnants also labelled positively for myosin VIIa suggesting a possible incipient deterioration in the cultures by this time ([Figure 1D](#fig1){ref-type="fig"}). This defined a period of 21--22 days for an optimal total time of incubation in subsequent experiments, a period of sufficient length to cover that over which spontaneous regeneration of hair cells occurs in the vestibular organs in vivo in guinea pigs ([@bib16], [@bib17]), chinchillas ([@bib37]) and mice ([@bib23]).

![Undamaged utricular maculae.\
(**A--C**) Fixed immediately after harvesting. (**D**) After 28 days in explant culture. (**A**) Hair cells labelled for myosin VIIa (red) are distributed over the entire utricle. Phalloidin labels actin (green) at the intercellular junctions at the luminal surface of the epithelium. Many of the junction-associated actin bands are quite wide, but others, mainly where hair cells have been lost, are thin. Scale bar: 50 µm. (**B**) SEM shows organised hair bundles of hair cells and surfaces of intervening supporting cells. Scale bar: 5 µm. (**C**) Hair cells do not contact the basement membrane underlying the epithelium and their nuclei are at a level above that of supporting cells, which are in contact with the basement membrane. Neuronal elements have rapidly died away from the hair cells. Scale bars: 5 µm. (**D**) Undamaged utricle maintained in explant culture for 28 days. Hair cells labelled for myosin VIIa (red) are distributed across the entire epithelium. Scale bar: 25 µm.](elife-34817-fig1){#fig1}

Gentamicin treatment results in extensive hair cell loss {#s2-2}
--------------------------------------------------------

To ablate hair cells we exposed utricles to the ototoxic aminoglycoside antibiotic gentamicin. At 24 hr following 48 hr exposure to 2 mM gentamicin, few intact hair cells remained. Apoptotic death of hair cells in the body of the epithelium was evident by positive immunolabelling for activated caspase 3 (not shown) and in thin sections for TEM by pyknotic nuclei or marginated chromatin, with apoptotic bodies inside supporting cells ([Figure 2A,B](#fig2){ref-type="fig"}). Some hair cells were also seen to be extruded from the epithelium ([Figure 2C](#fig2){ref-type="fig"}). Both apoptosis, with apoptotic bodies phagocytosed by supporting cells, and extrusion of hair cells from the epithelium have been observed to occur in the vestibular sensory epithelia in vivo in animals treated with aminoglycoside ([@bib34]). With loss of hair cells, supporting cells closed the lesions ([Figure 2D](#fig2){ref-type="fig"}). The number of hair cells in cultures treated with gentamicin (N = 16) was assessed by counting myoVIIa positive cells in two groups: an early timepoint, 2--4 days post-gentamicin (dpg) (N = 5); and a late timepoint, 11--21 dpg (N = 11). At the earlier stage there was a mean of 5.26 ± 1.48 per 10000 µm^2^. The hair cell bodies that persisted in the first few days after gentamicin exposure were scattered across the epithelium ([Figure 2E](#fig2){ref-type="fig"}). They were always rounded in shape and most contained an actin-rich rod-like inclusion structure ([Figure 2E,F,G](#fig2){ref-type="fig"}) indicative of pathology; they are reminiscent of the 'cytocaud' observed in damaged guinea pig vestibular hair cells ([@bib22]), and in mice appear in damaged hair cells destined for phagocytosis by supporting cells ([@bib4]). In tissue cultured for longer periods, up to 21 days post gentamicin treatment, there were very few hair cells ([Figure 2H](#fig2){ref-type="fig"}, ca. 1.4 ± 0.31 per 10000 µm^2^). The surfaces of almost all cells across the epithelium were of similar appearance ([Figure 2I](#fig2){ref-type="fig"}), with no surface projections or other structural specialisations, except for dispersed short microvilli, and with a polygonal outline, features characteristic of supporting cells following loss of hair cells. There was no evidence of spontaneous regeneration of hair cells. Thus, the prolonged high dose exposure to gentamicin ablated the majority of hair cells resulting in an epithelium composed predominantly of supporting cells.

![Hair cell loss in utricular maculae following incubation in gentamicin.\
(**A**) Hair cells undergoing apoptosis (arrows), indicated by the condensed marginated chromatin in their nuclei, at 24 hr after incubation in gentamicin. Scale bar: 2 µm. (**B**) Apoptotic body inside a supporting cell at 24 hr after incubation with gentamicin. Scale bar: 2 µm. (**C**) Hair cells in the process of extrusion from the sensory epithelium at 24 hr after incubation in gentamicin. Supporting cells below the extruding hair cell have formed tight junctions to close the space that the hair cell is vacating. Scale bar: 2 µm. (**D**) Four days after the end of incubation with gentamicin, few hair cell bodies are evident within the epithelium. Scale bar: 5 µm. (**E**) 2 days after incubation with gentamicin, remaining hair cells labelled for myosin VIIa (red) are almost all rounded in shape and enclose a phalloidin-labelled rod-like inclusion (green). Scale bar: 25 µm. (**F**) Rod-like inclusions composed of actin (labelled with phalloidin, green) are present in almost all remaining hair cells (labelled for myosin VIIa, red) at 24 hr after incubation with gentamicin. Nuclei labelled with DAPI (blue). Scale bar: 10 µm. (**G**) Thin section reveals rod-like inclusion composed of densely packed filaments in degenerating hair cell at 24 hr after incubation with gentamicin. Scale bar: 2 µm. (**H**) 21 days after incubation with gentamicin very few cells that label for myosin VIIa remain. Scale bar: 25 µm. (**I**) SEM of apical surface of utricle 21 days after incubation with gentamicin. There are no hair bundles or other obvious surface specialisations. The surfaces of almost all cells are relatively smooth, with variable numbers of short dispersed microvilli, and have a polygonal profile, characteristics of the apical surfaces of supporting cells in regions where hair cells have been lost. Scale bar: 20 µm.](elife-34817-fig2){#fig2}

Adenoviral transduction of human vestibular epithelium {#s2-3}
------------------------------------------------------

To promote hair cell generation by expression of exogenous *ATOH1* transduction we used a second generation multiply-depleted replication-incompetent adenoviral vector, Ad2, previously shown to transduce human hair cells and supporting cells in vitro ([@bib25]). The vector carried the genes for green fluorescent protein (GFP) and atonal homologue 1 (ATOH1) independently driven by CMV promoters. After ablation of hair cells by incubation with gentamicin, utricles (and some cristae) were thoroughly rinsed with medium and incubated for up to 24 hr with the viral vector in serum-free medium. Expression of GFP at 4 days after transduction showed that supporting cells in the human tissue could be efficiently transduced, and delineated variable shapes of supporting cells revealing some with thin basally directed projections ([Figure 3A](#fig3){ref-type="fig"}). Labelling for SOX2, which is expressed by supporting cells, showed that GFP was co-expressed in cells with nuclei positively labelled for SOX2 ([Figure 3B](#fig3){ref-type="fig"}). Expression of ATOH1 could be detected by immunolabelling in some cells expressing GFP both in utricles ([Figure 3C](#fig3){ref-type="fig"}) and in cristae ([Figure 3D](#fig3){ref-type="fig"}), but not all GFP expressing cells also expressed ATOH1. Likewise, myosin VIIa was also expressed in some cells expressing GFP but not others ([Figure 3E](#fig3){ref-type="fig"}). By 17 days after incubation with the virus (tissue cultured for a total of 20 days) many myosin VIIa-positive cells were apparent ([Figure 3F](#fig3){ref-type="fig"}). These myosin VIIA-positive cells were often tightly packed together, contacting each other in some regions of the tissue ([Figure 3G](#fig3){ref-type="fig"}) and of variable shapes, rarely rounded but often elongated and some with thin basally directed projections ([Figure 3H](#fig3){ref-type="fig"}.) Only some cells expressed both GFP and myosin VIIA ([Figure 3G,H](#fig3){ref-type="fig"}) but in many that did, GFP was less strongly expressed than in cells expressing GFP alone ([Figure 3G](#fig3){ref-type="fig"}), perhaps suggesting that GFP may be downregulated over time as cells differentiate. The number of cells expressing myoVIIa (14.54 ± 3.68, N = 7) was significantly greater than the number in control tissue from which hair cells had been ablated and then maintained for an equivalent period of time without further treatment ([Figure 4](#fig4){ref-type="fig"}).

![Sensory epithelia transduced with *ATOH1* and *GFP* after incubation with gentamicin.\
(**A**) GFP expression 2 days after transduction. Many supporting cells express GFP which delineates cell shape revealing several cells with thin, basally directed extensions (inset). Scale bar 20 µm. (**B**) Labelling for SOX2 (red), and **B'**) SOX2 and GFP expression, 2 days after transduction. Arrows indicate nuclei labelled for SOX2 (**B**) inside cells that express GFP (**B'**). Scale bar: 10 µm. (**C**) Frozen section. Labelling for ATOH1(red) and **C'**) ATOH1 with GFP expression in utricular macula 5 days after transduction. Arrows indicate nucleus labelled for ATOH1 (**C**) in cell that expresses GFP (**C'**). Adjacent cell, with basally directed extension expresses GFP but the nucleus does not label for ATOH1. Scale bar: 10 µm. (**D**) Frozen section. Labelling for ATOH1(red) and **D'**) ATOH1 with GFP expression in crista 5 days after transduction. Several cells whose nuclei label for ATOH1 also express GFP, but there are also cells with ATOH1 +nuclei which do not express GFP. Phalloidin-labelled actin, as well as DAPI to label nuclei, is in the blue channel to label the intercellular junctions as orientation for identification of the luminal surface of the epithelium. Scale bar: 10 µm. (**E**) Myosin VIIa (red) labels cell that also expresses GFP (**E'**). Adjacent cell, with morphological characteristics of supporting cell, expresses GFP but not Myosin VIIa. Scale bar: 10 µm. (**F**) 18 days after transduction, many cells label for Myosin VIIa (red). Scale Bar: 20 µm. (**G**) Myosin VIIa labelling, (**G'**) GFP expression, (**G''**) Merge of myosin VIIA labelling (red) and GFP at 18 days post transduction. Arrows indicate some cells expressing GFP that label for myosin VIIa. The intensity of labelling for myosin VIIa and the level of expression of GFP vary. Myosin VIIa labelled cells often clustered together and appear to be in contact. Scale bar: 10 µm. (**H**, **H'**) Some cells at 18 days after transduction that are labelled for myosin VIIa (**H**) and also express GFP (**H'**) have thin basally extended projections. Scale bar: 10 µm.](elife-34817-fig3){#fig3}

![Numbers of myosin VIIa positive cells per unit area.\
Number of labelled cells (25%--75% percentiles and maximum-minimum) in utricles following 48 hr incubation in gentamicin then maintained up to 28 days with no further treatment (Gentamicin only, control tissue N = 11); 18 days after transduction with *ATOH1* (N = 7); maintained 18 days in medium containing TAPI1 (N = 7); transduced with *ATOH1* and maintained 18 days in medium containing TAPI1 (N = 6). Asterisks indicate significant difference in the numbers of myosin VIIa positive cells in each treatment condition compared to the gentamicin only control.](elife-34817-fig4){#fig4}

Inhibition of the notch signalling pathway {#s2-4}
------------------------------------------

Studies in birds and mammals have shown that replacement hair cells can be derived from the supporting cells that remain after hair cell loss through inhibition of the Notch-signalling pathway ([@bib11]; [@bib35]; [@bib57]). To test the hypothesis that hair cell regeneration in human inner ear tissue could be induced by inhibition of Notch signalling, we maintained gentamicin treated cultures (N = 7) in TAPI-1 for 18 days. TAPI-1 is a potent small molecule inhibitor of matrix metalloproteinases and TACE (TNF-α convertase/ADAM17). Myosin VIIA+ cells were quantified and numbers compared with damaged utricles cultured for a similar duration (3.85 ± 1.2 vs 1.39 ± 0.3, respectively; [Figure 4](#fig4){ref-type="fig"}). Statistical analyses revealed a significant difference between gentamicin-only treated tissue and samples subsequently maintained with TAPI-1 (p\<0.05) but also that the number of myosinVIIA positive cells following incubation with TAPI1 was significantly less than that generated by ATOH1 transduction.

To test whether we could further enhance the generation of 'hair cells' seen in tissue transduced with ATOH1, we exposed damaged utricles (N = 6) to Ad2-ATOH1-GFP and then maintained them in medium with TAPI-1. Unexpectedly, the number of myoVIIA+ cells was lower than tissue transduced with Ad2-ATOH1-GFP and maintained in medium alone (8.39 ± 02.65). However, there were more myosin VIIA+ cells than found in damaged cultures exposed to TAPI-1 alone. Overall, the number of myoVIIa positive cells in all three treatment groups (ATOH1 transduced; TAPI-1 alone; and ATOH1 transduced +TAPI-1) was statistically significantly greater than that in gentamicin-only treated utricles ([Figure 4](#fig4){ref-type="fig"}) providing evidence that supporting cells can be manipulated to generate hair cell-like cells in human inner ear sensory epithelia. There was no significant difference in the mean ages of the donors in each treatment group and the age ranges were similar (control: mean 58.1, range 36--81; ATOH1 transduced: mean 55.7, range 41--67; TAPI1: mean 46.8, range 32--64; ATOH1 +TAPI: mean 46.7; range 20--71). This indicated that age is unlikely to be a factor underlying the difference between treatment regimes in the number of myosin VIIa cells generated.

Morphological assessment {#s2-5}
------------------------

In explants exposed to ATOH1, either with or without TAPI1, following the ablation of hair cells with gentamicin, SEM (3 samples of each condition) showed the apical surface of many cells across the epithelium had bushy microvillar projections that were noticeably longer than the microvilli of neighbouring cells ([Figure 5A](#fig5){ref-type="fig"}). Some cells had a central protrusion within the cluster of microvilli, reminiscent of the position of the kinocilium seen in immature hair bundles during development of the sensory epithelia and hair cell regeneration ([@bib13]; [@bib17]; [@bib52]; [@bib53]) ([Figure 5B,C](#fig5){ref-type="fig"}). The projections were present on cells that expressed GFP and labeled for myosin VIIa and were composed of actin ([Figure 5D](#fig5){ref-type="fig"}), but no cells showed organized hair bundles, and in whole mount samples prepared for immunolabelling, very little labelling for espin, a known actin bundling protein expressed along the length of stereocilia ([@bib63]), could be detected. In thin sections, cells with prominent elongated microvilli were identified. They were also evident in samples that had first been examined by SEM (two samples) ([Figure 5D,E](#fig5){ref-type="fig"}) as well in samples which had been embedded after immunolabelling for myosin VIIa (two samples) ([Figure 5F,G](#fig5){ref-type="fig"}). These cells showed some features resembling hair cells: they were generally cylindrical in shape with a rounded nucleus located towards the luminal pole and, when their profiles were followed through the serial sections, they were not in contact with the basement membrane, although some cells had thinner elongated basal projections similar to that seen with myosin VIIA labelling and expected of a cell converting from a supporting cell ([@bib33]; [@bib50]). However, these cells did not possess cuticular plates - the actin meshwork that forms a platform beneath the stereocilia in differentiating hair cells - nor were there any synaptic specializations such as synaptic ribbons ([@bib51]). Thus, it appeared that while cells expressing hair cells markers could be generated, those cells did not differentiate fully as hair cells.

![Morphological characteristics of cells in utricles 18 days after transduction with *ATOH1*.\
(**A**) Many cells across the epithelium bear elongated microvillar-like projections from their apical surface. Scale bar: 5 µm. (**B, C**) Cells with dense cluster of apical projections possess a single thicker, kinocilium-like projection from the centre of the cell surface (arrowed). Scale bars: 1 µm. (**D**) Thin projections on cells expressing myosin VIIa (red) and GFP contain actin (blue). Scale bar: 2 µm. (**E,F**) Thin sections of cells in utricle in which SEM showed cells with dense clusters of apical projections in panel A, and (**G,H**) in a utricle that showed large numbers of myosin VIIa labelled cells after immunolabelling similar to the utricle shown in [Figure 3](#fig3){ref-type="fig"} panel F. In cells with numerous, microvillar projections, nuclei are located towards the apical (luminal) surface and have approximately cylindrical cell bodies, similar to hair cells, but some (panels E and H) have thinning basal extensions, reminiscent of supporting cells converting to hair cells. Scale Bars: 2 µm.](elife-34817-fig5){#fig5}

Gene expression changes with Ad2-ATOH1-GFP transduction {#s2-6}
-------------------------------------------------------

To investigate alterations in gene expression after Ad2-ATOH1-GFP transduction of human supporting cells, we measured transcriptome changes by RNA-seq. We compared gentamicin-treated tissue transduced with Ad2-ATOH1-GFP cultured for 5 days, versus control tissues only treated with gentamicin (cultured for 2 days, 8 days and 14--18 days). Three separate comparisons were performed between the Ad2-ATOH1-GFP transduced tissues and the three different controls to limit the variability between control samples and derive a consistent set of gene expression changes. Based upon this stringent comparison, a total of 494 genes were significantly differentially expressed (−2 \>= fold change \>= 2 and p\<0.05 across all three comparisons). The expression of 441 out of these 494 genes exhibited the same direction of change in all three comparisons. Of these, 53 were down-regulated by ATOH1 transduction whereas 388 were upregulated. ATOH1 was among the most significantly overexpressed genes in tissues transduced with ATOH1 (70 to 286-fold \< p \< 0.05).

Within the 441 significantly differentially expressed genes we were interested in identifying key regulatory genes that showed consistent changes in gene expression. Including ATOH1, a total of 18 transcription factors (TFs) and five known chromatin modifiers (CMs, one gene SATB2 has both activities) fall into this class. These are shown in [Table 1](#table1){ref-type="table"}. To validate results from the RNA-sequencing, quantitative RT-PCR was conducted on five of the genes listed in [Table 1](#table1){ref-type="table"}. These were *CITED, IRF9, SNAI1, EP300* and *HDAC9*. In all cases the trends for fold-changes were the same as in RNA-seq and in most cases they were very close in actual values ([Figure 6](#fig6){ref-type="fig"}).

![Average RQ values in Log2 fold-change for ATOH1 treated versus controls from Taqman (blue) compared to Log2 fold-change measured by RNA-seq (red).](elife-34817-fig6){#fig6}
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###### Transcription factors and chromatin modifiers that exhibit significant changes in gene expression upon Atoh1 transduction into human sensory epithelia.

The left column lists gene names followed by gene descriptions. AB T is the average transcript abundance in the Atoh1 treated samples (as FPKMs). AB C is the average abundance in the control samples. LOG2 is the log base2 fold change of Atoh1 transfected compared to the controls. FUNCT indicates whether a given gene is a transcription factor (TF) or a chromatin modifier (CM). Names in bold are genes that show a \> 2 fold change in expression (and p\<0.05) across all three comparisons (they are part of the 441 differentially expressed genes, see Materials and methods and Results). Genes in plain text show statistically significant changes in all comparisons, but only pass \>2 fold in at least one comparison.

  GENE       Description                                  Ab T    Ab C   LOG2   Funct
  ---------- -------------------------------------------- ------- ------ ------ -------
  ATOH1      atonal bHLH transcription factor 1           37.8    0.3    6.9    TF
  RAX        retina and anterior neural fold homeobox     0.7     0.1    2.5    TF
  ZNF296     zinc finger protein 296                      17.1    3.0    2.5    TF
  POU4F3     POU class 4 homeobox 3                       3.4     0.8    2.1    TF
  CITED4     Cbp/p300 interacting transactivator          56.6    13.7   2.0    TF
  GTF2IRD2   GTF2I repeat domain containing 2             2.7     0.7    2.0    TF
  SNAI1      snail family transcriptional repressor 1     30.7    8.9    1.8    TF
  ZNF775     zinc finger protein 775                      17.8    5.9    1.6    TF
  MEF2B      myocyte enhancer factor 2B                   2.1     0.7    1.6    TF
  SOX12      SRY-box 12                                   10.1    3.6    1.5    TF
  ZNF784     zinc finger protein 784                      3.7     1.3    1.4    TF
  ZNF837     zinc finger protein 837                      1.8     0.7    1.4    TF
  IRF9       interferon regulatory factor 9               137.3   53.5   1.4    TF
  ZNF692     zinc finger protein 692                      36.7    15.1   1.3    TF
  GTF2H3     general transcription factor IIH subunit 3   9.3     21.5   −1.2   TF
  ZNF382     zinc finger protein 382                      0.9     2.2    −1.2   TF
  EP300      E1A binding protein p300                     10.9    26.3   −1.3   CM
  ZFHX4      zinc finger homeobox 4                       1.0     2.4    −1.3   TF
  ASH1L      ASH1 like histone lysine methyltransfer      5.1     12.8   −1.3   CM
  ATRX       ATRX, chromatin remodeler                    7.0     22.4   −1.7   CM
  SATB2      SATB homeobox 2                              0.8     3.0    −1.9   TF/CM
  HDAC9      histone deacetylase 9                        5.7     20.9   −1.9   CM
  TCF19      transcription factor 19                      0.7     0.2    1.8    TF
  HES1       hes family bHLH transcription factor 1       78.1    24.1   1.7    TF
  ZNF467     zinc finger protein 467                      4.3     1.5    1.5    TF
  GSC        goosecoid homeobox                           0.8     0.3    1.5    TF
  SALL1      spalt like transcription factor 1            9.7     3.9    1.3    TF
  KCNIP3     potassium voltage-gated channel protein 3    10.1    4.3    1.3    TF
  THAP3      THAP domain containing 3                     30.6    13.2   1.2    TF
  MSX1       msh homeobox 1                               8.4     3.7    1.2    TF
  SCAND1     SCAN domain containing 1                     58.9    26.8   1.1    TF
  ING2       inhibitor of growth family member 2          13.2    6.1    1.1    CM
  MLXIP      MLX interacting protein                      8.8     4.2    1.1    TF
  ZNF652     zinc finger protein 652                      11.4    5.7    1.0    TF
  PATZ1      POZ/BTB and AT hook containing zincfinger    18.1    9.3    1.0    TF/CM
  RARG       retinoic acid receptor gamma                 18.0    9.2    1.0    TF
  GLI4       GLI family zinc finger 4                     13.1    6.8    1.0    TF
  THAP8      THAP domain containing 8                     7.5     4.3    0.8    TF
  ING5       inhibitor of growth family member 5          17.5    10.4   0.8    CM
  TAF6       TATA-box binding protein associated factor   42.6    26.1   0.7    TF
  ZNF768     zinc finger protein 768                      47.2    29.3   0.7    TF
  CREBBP     CREB binding protein                         11.6    21.8   −0.9   TF

It is interesting to note from [Table 1](#table1){ref-type="table"} that only four of the TFs and all of the CMs exhibit downregulation after ATOH1 transduction. The vast majority of the TFs are upregulated. Among the upregulated TF genes, six are of particular note (ATOH1, POU4F3, RAX, ZNF837, GTF2IRD2 AND MEF2B) since they are induced from close to zero to a significant level of transcript abundance (abundance levels are shown in [Table 1](#table1){ref-type="table"}). The remaining TFs appear to already be present at significant abundance levels in gentamicin-treated controls.

19 putative HC markers (ACTC1, ATOH1, CCDC60, CES2, ENO2, EPS8L2, HIST3H2A, JAG2, OBSCN, ODF3B, PKN3, POU4F3, RABL2A, RAX, SYTL1, SYT7, TAS1R1, UBXN11, UNC5A) and six putative downstream targets of ATOH1 (EPS8L2, JAG2, OBSCN, PKN3, POU4F3, UNC5A) ([@bib7]), plus 4 markers of HC bundles (EPS8L2, GPI, PFKL, UBA7) ([@bib48]) show significant upregulation in the ATOH1-treated samples. *MYO7A*, is also overexpressed in *ATOH1*-transduced tissues compared to all three controls but did not reach statistical significance. These markers of HC maturation are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. A large number of additional established hair cell markers (\>150) exhibit consistent upregulation in all three comparative analyses, but failed to pass the statistical threshold of significance (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}). Overall, of the 1375 putative HC markers we searched for within the upregulated gene expression dataset, a total of 335 were detectable and upregulated. These data support the contention that ATOH1 upregulation is driving towards an incomplete program of HC differentiation.

Enrichment analysis using ToppGene Suite ([@bib8]) showed that GO biological processes such as muscle filament sliding and muscle system process were significantly enriched (FDR \< 0.01). These processes included actin, myosin and troponin genes which suggests that hair cell bundles might be forming in the ATOH1-transduced tissues. However, most of these genes encoded relatively low abundance transcripts within the total dataset. Interestingly, there was also a significant enrichment of genes with TF binding sites for TCF3 and MEF2A/B transcription factors (FDR \< 0.01). TCF3 is a known ATOH1 co-factor ([@bib40]) and is overexpressed in the ATOH1-transduced tissues compared to all three controls but failed to reach statistical significance. MEF2A is not differentially expressed within our data but, as noted above, MEF2B is induced three-fold from a basal level in ATOH1-transduced tissues. These may represent possible potentiators of ATOH1 function.

This unbiased transcriptomic analysis further supports the premise that manipulation of cell fate with gene modification enhances the conversion of supporting cells to a transcriptional signature that overlaps with known markers of the hair cell phenotype.

Discussion {#s3}
==========

The objective of the study was to determine whether supporting cells in the vestibular sensory from adult humans can be induced to generate cells with hair-cell like features. As we illustrated previously ([@bib51]) the number of hair cells normally present in the vestibular sensory epithelia of humans may vary widely mainly due to ageing (and genetic variations that likely affect how susceptible to the effects of ageing different individuals might be). Consequently, the initial goal was to try to ablate as many hair cells as possible to create conditions that were essentially the same for all samples, with almost no hair cells present, and generate an epithelium composed predominantly of supporting cells. This was the starting point to test the capacities of supporting cells and also to remove possible confounds presented by any remaining hair cells. This condition also would mimic something similar to what we ([@bib51]) and others ([@bib61]) have shown to be the situation in the vestibular sensory epithelia of elderly people who might be the ones to benefit from a regenerative strategy were one available. The prolonged (48 hr), high dose (2 mM) gentamicin treatment we used was designed to achieve this condition and the results indicate that this was largely accomplished.

Previous work has suggested that supporting cells in the mature utricular maculae of mice can be induced to convert towards a hair cell fate ([@bib35]; [@bib49]). The present results demonstrate, not only from expression of hair cell marker proteins but also from analysis of expressed genes, that a similar plasticity of the supporting cell phenotype is retained in the vestibular tissues of humans. In our work, we made no distinction between samples on the basis of age but it has been suggested that age may influence the ability of supporting cells to regenerate lost hair cells. In mammals, a capacity of post-mitotic supporting cells in immature early postnatal (mouse) tissue to respond to regenerative signals or to generate new hair cells is dramatically reduced in the mature tissue of pre-weaner juveniles or young adults ([@bib5]; [@bib18]). The number of cells in the mature vestibular system that have a 'stem cell'-like capacity to form spheroids also declines with age ([@bib43]). However, there is nothing to suggest that in the mature inner ear the activities of supporting cells are affected by age. In the present case, all our material was taken from adults the majority of whom were at the older end of the age range (mean 50.4 years, median 51). Yet in all cases where it was examined, supporting cells retained their capacities to effect repair of the epithelium and maintain tissue integrity. Loss of hair cells was accompanied by concurrent closure of the lesion by expansion of supporting cells, initially with the formation of characteristic scar formations ([@bib41]; [@bib34]; [@bib51]). The supporting cells also removed apoptotic bodies efficiently and acted to extrude damaged hair cells, in a manner very reminiscent of the similar processes occurring in vivo in animals following lethal damage to vestibular hair cells. In our earlier work we also showed through dye loading experiments the continuing viability of the supporting cell syncytium in tissue taken from the same population of patients as in this study, and in which there was significant hair cell loss. ([@bib51]). The retention of these capacities and activities seemingly regardless of age or ex vivo maintenance would point to the health of the tissue used in this work and also to the likelihood that the capacity of supporting cells to be converted is maintained throughout life in people. This is consistent with our earlier observations ([@bib51]) of occasional cells bearing immature hair bundles in the utricular maculae of elderly patients where most mature hair cells had been lost 'naturally', suggesting a very low level of spontaneous hair cell generation may be ongoing in the human vestibular sensory epithelia. Interestingly, it has been suggested that in birds, the capacity to regenerate hair cells from the supporting cell population continues unabated throughout life ([@bib30]).

We found that viral vector-mediated transduction with ATOH1 resulted in generation of highly significant numbers of myosin VIIA positive cells but the use of TAPI1 alone was not as successful. Since the ages of the donors of the tissues used in the TAPI1 experiments was not significantly different from those that were transduced with ATOH1 age is not a factor underlying the difference in the number of cells expressing the hair cell marker protein generated by the treatment regimes. TAPI1 has been shown to be an inhibitor of the Notch pathway that can induce hair cell regeneration in adult mouse utricles ([@bib35]) and we used TAPI1 at a concentration the same as that used in that study. Other, γ-secretase inhibitors (GSIs) DAPT ([@bib35]) and LY411575 ([@bib42]) have also been used to regenerate hair cells in murine inner ear tissues. We performed a small number of studies with both of these GSIs, again using doses reported in the literature to be effective in mouse tissue, but neither produced significant numbers of cells expressing myosin VIIa. However, the number of samples examined was insufficient to draw any definitive conclusion as to their efficacy in inducing generation of hair cells. It may also be that higher concentrations of agents that inhibit the Notch pathway are required in the human tissue than in mouse and this may warrant further investigation.

Cells expressing myosin VIIA+ did not form organised hair bundles. The emergence of numerous cells bearing bushy bundles of microvilli in tissues in which Myo VIIa positive cells were generated but not in tissue maintained in culture for similar period but in which only hair cell ablation had occurred, further confirms phenotypic changes to supporting cells. These apical surface characteristics bear a striking resemblance to 'hair-cell-like' cells generated from human embryonic stem cells as described by [@bib45] as well as those defined as hair cells generated in the mouse organ of Corti by genetic co-manipulation of Atoh1 and P27^Kip1^ ([@bib56]). However, it would appear that additional factors or further manipulations are required to generate fully differentiated hair cells, a contention supported by our findings that several genes that have been reported to be part of the cascade that follows *Atoh1* expression during the initial embryonic formation of hair cells are not expressed. A similar conclusion is drawn from a recent report ([@bib56]) that *Atoh1*-based hair cell regeneration therapies in mouse cochleae may be enhanced by genetic manipulation of p27^kip1^,Gata3 or Pou4f3. From our transcriptional analysis we have identified transcription factors and chromatin modifiers that may play roles in the ATOH1 induced cascade. However, the most glaring absentee from this cascade is GFI1 which is believed to lie downstream of ATOH1 and POU4F3 ([@bib21]) in the (still ill-defined) TF network that specifies a mature hair cell. In mice lacking *Gfi1* 'hair cells' are generated during development but they show morphological abnormalities and fail to form hair bundles ([@bib55]). Also, in embryoid bodies derived from mouse stem cells the co-expression of *Gfi1* and *Pou4F3* as well as *Atoh1* was required to generate cells with hair bundle-like structures ([@bib10]). Since there was significant up-regulation of *POU4F3* expression following the *ATOH1* transduction of the human utricular maculae, it would point to *GFI1* expression as an interesting candidate gene necessary for inducing hair cell differentiation. Gfi1 has been reported to act as a transcriptional regulator acting through chromatin modification ([@bib15]). Identification of genes regulated by Gfi1 would also be of interest in a search for factors to induce regeneration of functional hair cells.

The expression of GFP showed that the supporting cells in the human utricular macula can be transduced with quite high efficiency with the Ad2 viral vector, consistent with prior reports ([@bib25]). Efficient transduction of the supporting cells in the human utricle can also be accomplished with a synthetic AAV vector Anc80L65 ([@bib32]). This indicates that other genetic manipulations of human vestibular sensory epithelia are possible and could potentially form the basis for other therapeutic interventions. One known receptor for adenovirus is αvβ5 integrin ([@bib38]; [@bib59]) and in other work (Taylor, Hussain and Forge, in preparation) using RT-PCR screening we have found both these integrin subunits to be expressed in the human vestibular epithelia although as yet we do not know if they are partnered. Nevertheless, this may be the basis of the efficient transduction with adenoviral vectors. However, some cells that expressed GFP did not appear to express ATOH1 and some cells that expressed ATOH1 did not show expression of GFP. One reason for this maybe that the two genes were driven by independent CMV promoters so may not have always been expressed together or they were expressed at differing levels and sometimes below the level of detection.

The generated cells expressing Myo VIIa, as well as the cells bearing bushy microvillar bundles, were often closely clustered together, sometimes seemingly in contact with each other. The pattern of distribution of hair and supporting cells that is normally present in the utricular macular where each hair cells is surrounded and separated from it neighbours by intervening supporting cells was not restored. This may imply that the signalling pathways through which differentiating hair cells instruct their immediate neighbours to adopt a different, supporting cell, fate from themselves may not be properly active in these conditions where hair cells are induced.

Conclusions {#s3-1}
-----------

Here we demonstrate the plasticity of the human vestibular epithelia via manipulation of developmental pathways using a viral vector to transduce supporting cells. The capacity of this vector to incorporate ATOH1 into sufficient supporting cells and subsequently yield large numbers of myosin VIIa+ cells supports our contention that it is possible to regenerate damaged epithelium and offers a therapeutic intervention to balance disorders caused by hair cell loss.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\   Designation               Source or reference         Identifiers       Additional information
  or resource                                                                                       
  ------------------------- ------------------------- --------------------------- ----------------- ------------------------
  Biological sample         Ad2 -CMV ATOH1:CMV-GFP\   Kesser et al.,\                               
                            viral vector              Laryngoscope 118:821--831                     

  Antibody                  anti-myosin VIIa          Developmental Studies\      DSHB myo7a138-1   (1:100)
                                                      Hybridoma Bank                                

  Antibody                  anti-espin                J. Bartles (Gift)                             (1:50)

  Antibody                  anti sox 2                Abcam                       ab97959           (1:100)

  Antibody                  anti-ATOH1                Aviva Bio Systems           ARP 32365_P050    (1:100)

  Antibody                  FITC, TRITC secondaries   Sigma                                         (1:200)

  Other                     Vectorshield with DAPI    Vector Laboratories         H-1200            
  --------------------------------------------------------------------------------------------------------------------------

Collection and maintenance of tissue {#s4-1}
------------------------------------

Human vestibular tissue was obtained as previously described ([@bib51]). Briefly, utricular maculae (utricles) and sometimes cristae were collected anonymously following informed consent from patients undergoing excision of vestibular schwannoma (acoustic neuromas) via a trans-labyrinthine approach. Excised tissue was transported from participating hospitals in medium used for long term culture.

Each explant culture was incubated at 37°C in a 5% CO~2~ atmosphere in one well of a 24 well plate, free floating in 0.5 ml Minimal Essential Medium (MEM) with glutamax (Gibco), 1% HEPES (N-2-hydroxyethylpiperazine-N-2ethanesulfonic acid) and 10% fetal bovine serum (Hyclone). The medium was supplemented with ciprofloxacin and amphotericin B to prevent contamination. To ablate hair cells, tissue was exposed to 2 mmol/L gentamicin for 48 hr and subsequently rinsed thoroughly with fresh medium before maintenance for up to 21 days with 50% of the medium changed on alternate days.

Ad2-ATOH1-GFP transduction of cells {#s4-2}
-----------------------------------

Replication deficient second generation adenovirus (Ad2) with deleted E1, E3, pol, pTP regions was used as vector ([@bib25]; [@bib26]). The Ad2 virus contained two expression cassettes each driven by the human cytomegalovirus promoter: *CMV-ATOH1* and *CMV-GFP*. Aliquots of Ad2-ATOH1-GFP viral vector stock were stored at −80°C until required. Following gentamicin treatment, tissue was rinsed three times in serum-free medium containing ciprofloxacin and incubated for up to 24 hr but no less than 18 hr in 200 μL of serum-free medium with a dilution of Ad2-ATOH1-GFP to give 1 × 10^8^ total particles per ml. Tissue was then rinsed five times with MEM with glutamax with serum to halt the transduction and maintained in this medium for a further 17 days. Cultures were rinsed and processed for immunohistochemistry or electron microscopy as described below.

The Notch pathway was inhibited using the TACE inhibitor TAPI-1. Gentamicin-treated samples were maintained in medium +50 μM TAPI-1 (Sigma-Aldrich, Poole) throughout the duration of culture. Initially TAPI-1 was dissolved in DMSO and further diluted with medium to give a stock solution of 1 mM that was stored at −20°C. These utricles were rinsed, fixed and processed for immunohistochemistry or electron microscopy.

Six lesioned utricles were transduced with Ad2-ATOH1-GFP and then incubated continuously in medium containing TAPI-1 as for the above samples. They were processed for immunohistochemistry or electron microscopy.

Tissue processing {#s4-3}
-----------------

Tissue for immunohistochemistry was fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline solution (PBS) for 90 min. The majority of samples were prepared as whole mounts with a small number prepared for cryosectioning. Whole mounts were rinsed in PBS and permeabilized using 0.5% Triton X-100 for 20 min and placed in blocking solution (10% goat serum, 0.15% Triton in PBS). Tissue was incubated overnight at 4°C in primary antibody, rinsed thoroughly in PBS and then incubated for 2 hr at room temperature with the appropriate secondary antibody conjugated to a fluorophore. Primary antibodies used were: mouse monoclonal against myosin VIIA (Developmental Studies Hybridoma Bank; myo7a 138--1) used at a dilution of 1:100; a rabbit polyclonal against espin (a kind gift from J Bartles) used at 1:50; a rabbit polyclonal against sox 2 (Abcam, ab 97959) at 1:100 and a polyclonal against Atoh1 (Aviva Systems Biology, ARP 32365_P050) at 1:100. A Tyramide signal amplification kit (Molecular Probes) was used according to manufacturer's protocol to amplify the Atoh1 labelling in tissue. Tissue was incubated in the appropriate secondary antibody (sheep anti-mouse (Zymed), or goat anti-rabbit (Sigma)) at 1:200. A fluorescent phalloidin conjugate (Sigma) was added at 1 μg/ml to the secondary antibody solution to label filamentous actin. Following staining, utricles were mounted onto slides using Vectashield with DAPI (Vectorlabs) to label nuclei. Samples were examined and images captured with a Zeiss LSM 510 confocal microscope.

For cryosections, fixed tissue was incubated in 30% sucrose solution overnight at 4°C embedded in low-temperature setting agarose and mounted in the required orientation. Cryosections of 15 μm were cut and collected on polylysine coated slides (VWR). Immunolabelling was performed as for whole mounts.

For scanning electron microscopy (SEM) and transmission electron microscopy (TEM) cultured utricles were rinsed and fixed in 2.5% glutaraldehyde in 0.1 mol/L cacodylate buffer for 2 hr and subsequently post-fixed in 1% OsO4 for 1.5 hr. Utricles for SEM, were then processed following the repeated thiocarbohydrazide-osmium procedure ([@bib12]), dehydrated in an ethanol series and critical point dried. Samples were mounted on support stubs using silver conductive paint and sputter coated with platinum before examination and collection of digital images on a Jeol 6700F instrument. Tissue for thin sectioning was partially dehydrated to 70% ethanol and stained 'en bloc' with uranyl acetate in 70% ethanol before completing dehydration and embedding in plastic. Some immunolabelled whole mount samples were removed from the slides after confocal microscopy, fixed in glutaraldehyde and OsO~4~ and processed for thin sectioning. Some samples examined by SEM also were prepared for thin sectioning. They were removed from the specimen support stubs into acetone, then into 100% ethanol before embedding in plastic. For all plastic embedded samples, serial thin sections across the entire width of each utricle were collected at a minimum of three depths separated by ca. 50 µm. Sections, some mounted on formvar --coated single slot grids, were stained with aqueous uranyl acetate and lead citrate and examined in a Jeol1200EXII instrument. Digital images were acquired with a Gatan camera. Sections on grids were also examined and imaged in the SEM using back-scatter detection to provide uninterrupted views of the entire width of the section.

Quantification {#s4-4}
--------------

Myosin VIIA+ cells were viewed and quantified from z-stacks of confocal images viewed in Image J.. Assessment was made of at least two different fields on a single utricle viewed with a x20 objective, with a random movement in X and Y planes between each field. In each field intact Myo VIIa positive cells with a distinct nucleus were counted in a delineated, measured area of at least 20,000 µm^2^ enclosing continuous intact epithelium as defined by phalloidin labelling of cell-cell junctions at the luminal surface, and excluding regions where the epithelium was folded over on itself, or was significantly disrupted, which occurred in several samples during prolonged incubation and processing due to the friability of the tissue and detachment of the epithelium from the underlying mesenchyme. At each location, each individual optical section through the entire depth of the epithelium was analysed. Cell counts were normalised to a unit area of 10000 um^2^.

Data analysis {#s4-5}
-------------

Using Prism4 GraphPad, discrete comparisons were made between each individual treatment group and the gentamicin only treated cultures maintained for similar lengths of time (control) using t-tests. ANOVA with Tukey correction was used to assess whether there were significant differences between the treatment groups.

Sample size calculations for transcriptome analysis {#s4-6}
---------------------------------------------------

Previous mRNA-Seq data derived by the Lovett group ([@bib31]) were used to calculate the median coefficient of variation in gene expression across samples when FPKM (Fragments Per Kilobase Of Exon Per Million Fragments Mapped) values \> 1 were used. Based on the model published by [@bib19], two biological replicates per treatment group are needed to detect a 2-fold difference with 80% power and 0.1 type 1 error, if 6 samples are multiplexed per lane (\~1000 read counts per transcript). Based on these calculations, in this study we sequenced 2 replicates for the treatment group and 2 replicates for the control group (14--18 days post gentamycin only). Two additional control samples (2dpg and 8 dpg) were available and therefore these were also used in the statistical analysis as described in the methods section. Three untreated samples were also sequenced and used in the ANOVA model but no comparisons with these were performed for the purposes of this study.

Transcriptome analysis {#s4-7}
----------------------

Six whole utricle samples (as pure as possible) were used for transcriptome analysis: Ad2-ATOH1-GFP transduced utricles cultured for 5 days after gentamicin treatment (two biological replicates), a utricle cultured for 2 days post gentamicin (early time-point, first control), one utricle cultured for 8 days post gentamicin (mid time-point, second control) and two utricles cultured for 14--18 days post gentamicin (late time-point, these two samples were grouped and used as the third control group). Following treatment, all utricles were collected into RNA-later. RNA was extracted using Zymo Research Quick-RNA MicroPrep kit. Libraries were prepared using Illumina Truseq Stranded mRNA Library Prep kit. 75 bp paired-end sequencing was performed on the Illumina HiSeq platform by service provider CNAG, Barcelona, Spain. Raw reads in fastq format were trimmed to remove adapter sequences and low-quality bases (Q \< 30) from the 3' end of reads using Cutadapt v1.9 ([@bib39]), then aligned against hg38 using Tophat v2.1 ([@bib28]) and expression values (FPKMs) were generated using Cufflinks v2.1 ([@bib54]) based on ensembl87 annotations. A filtering step was applied with at least one sample to be ≥0.5 FPKM. All sequencing data from all of these samples have been deposited in NCBI GEO (number applied for).

The utricle samples were not age-matched and due to possible genetic variability, Ad2-ATOH1-GFP transduced samples were compared against different control samples treated with gentamicin only. Three comparisons between Atoh1-transduced utricle samples against gentamicin-treated only samples were performed using one-way Anova on Partek Genomics Suite software: a) Atoh1-transduced versus 2 days post-gentamicin control sample; b) Atoh1-transduced versus 8 days post-gentamicin control sample and c) Atoh1-transduced versus 14--18 days post-gentamicin group of controls). Biological replicates and the group of control gentamicin-treated samples for 14--18 days had an average spearman's rho of 0.92. Statistical significance was considered when p\<0.05 and −2 ≤ fold change≥2 and fold changes were in the same direction across the three comparisons. Statistically significant differentially expressed genes were uploaded in ToppGene ([@bib8]) to identify enriched GO biological processes (FDR \< 0.05) and GeneMANIA ([@bib58]) to identify literature-supported interactions.

Quantitative RT-PCR {#s4-8}
-------------------

Taqman assays for *CITED, IRF9, SNAI1, EP300* and *HDAC9* (Hs 00388363, Hs00196051, Hs00195591, Hs00914223 and Hs-1081558) were purchased from ABI and were run in technical triplicates on an ABI QuantStudio Real Time PCR System under manufacturer's standard parameters for comparative C~T~ analysis. Total polyA+ RNA from two *ATOH1* utricle transduction experiments (5 days post gentamicin) were separately converted into cDNA. These were then pooled and constituted the *ATOH* samples. Total polyA+ RNA from three control utricle samples (2 days, 8 days and 14 days post gentamicin) were separately converted into cDNA. These were then pooled and constituted the control samples. Amplifications were normalized to a GAPDH internal control (ABI Taqman assay Hs99999905).
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###### Known and putative hair cell markers that exhibit upregulation in gene expression upon Atoh1 transduction into human sensory epithelia.

The left column lists gene names followed by gene descriptions. AB T is the average transcript abundance in the Atoh1 treated samples (as FPKMs). AB C is the average abundance in the control samples. LOG2 is the log base2 fold change of Atoh1 transfected compared to the controls. REFERENCE indicates the published results showing supportive evidence that the given gene is a putative hair cell marker (1) [@bib7]; (2) [@bib47]; (3) [@bib48]. Names in bold are genes that show a \> 2 fold change in expression (and p\<0.05) across all three comparisons (they are part of the 441 differentially expressed genes, see materials and methods and results). Genes with an asterisk (\*) are putative Atoh1 downstream targets based on Groves et al publication. Genes in plain text and above the thick bottom line show statistically significant upregulation in all comparisons, but only pass \> 2 fold in at least one comparison. Genes below the thick bottom line do not pass any of the above significance thresholds and show at least upregulation in all comparisons.

10.7554/eLife.34817.011

Data availability {#s7}
-----------------

All sequencing data from all of these samples have been deposited in NCBI GEO (accession number: GSE109320).

The following dataset was generated:

Forge ATaylor RRFilia AParedes UAsai YHolt JRLovett M2018Regenerating hair cells in human vestibular sensory epithelia[www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109320](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109320)Publicly available at the NCBI Gene Expression Omnibus (accession no. GSE109320)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Regenerating hair cells in human vestibular sensory epithelia\" for consideration by *eLife*. Your article has been reviewed by Andrew King as the Senior Editor, Tanya Whitfield as the Reviewing Editor and three reviewers. The following individual involved in review of your submission has agreed to reveal his identity: Jordi Llorens (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This article evaluates the potential for inducing hair cell regeneration in cultured utricles from adult humans. It is concluded that *ATOH1* transduction stimulates an incipient regeneration of hair cells in utricles damaged in vitro by gentamicin, but that the stimulus is insufficient to generate maturely differentiated hair cells. Similar, but quantitatively smaller, effects were obtained by pharmacological blockade of the Notch signalling pathway. The study of the gene expression changes after *ATOH1* treatment open a powerful way to future progress in understanding the requirements for hair cell regeneration.

Essential revisions:

As you will see, all three reviewers are largely positive about the study, but each has a number of queries regarding the data and methodology, particularly relating to the cell counting methods and statistical analysis, together with age and disease status of the patients. Additional validation and retrospective analysis of existing data are suggested where this would clarify the interpretation and conclusions. The full reviews are appended below.

Reviewer \#1:

Thanks to previously described consortium of surgeons and protocol (Taylor et al., 2015), these cultures represent a unique opportunity to study candidate therapeutic approaches in the adult human tissues where these treatments would be used at the end. This major strength bears inevitably the major weakness of the study, the difficulty in obtaining homogeneous and large groups of samples for complete analysis. The model imposes an experimental design of one sample at a time, so experimental groups are constructed over months. Under these circumstances, one must admit that some questions that would require an answer in animal studies cannot be realistically asked in this model. However, there are several important aspects that should be somehow addressed or at least fairly discussed by the authors.

1\) The first question is on the viability of the hair cells in vitro, and the basal conditions on which the lesion/regeneration model is compared with. In subsection "Untreated utricles" one reads \"Hair cells survived in vitro in untreated samples maintained in explant culture for up to 21 days\", but also \"Condensed, misshapen remnants of dying cells also immunolabelled positively for myosin VIIa\". The second sentence reveals that the culture conditions are suboptimal and progressively cause hair cell death, thus denying the first sentence. Therefore, to allow for a good appraisal of the damage and regeneration capacities of the utricles in the model, the article should include data of hair cell density in the cultures before gentamicin treatment, and in untreated utricles after 18-20 days in culture. A fair estimation of these densities should be possible retrospectively from stored images of the experiments reported, or from ongoing experiments. Otherwise, this aspect should be discussed.

2\) The presence of elongated microvilli (Figure 5A) in damaged utricles treated with *ATOH1* is shown. However, their absence (or smaller presence) in damaged untreated utricles or in non-damaged utricles is not shown. The authors must have this evidence to support their conclusion.

3\) The *MYO7A*+ data are analyzed by multiple t-test of damaged+treated groups versus a common single damaged-untreated group. The data should instead be analyzed by one-way ANOVA followed by an appropriate post-hoc test for multiple comparisons.

4\) The age of the donors in each group must be shown and compared, to eliminate the possibility that the observed differences among groups are due to age differences. In fact, the image in Figure 1A shows a density of hair cells much lower than that expected in young adult mammals, suggesting that this utricle suffers hair cell loss, probably related to the age of the donor (Taylor et al., 2015). May this explain the unexpected finding that ATOH1+TAPI-1 utricles showed less *MYO7A*+ cells than the ATOH1 alone utricles?

Reviewer \#2:

The submitted manuscript by Forge\'s research group characterizes the response of *Atoh1* gene transfer into the cultured human utricles. This is an important topic because there are very few studies describing how the human inner ear regenerates in response to manipulation. Overall, the study is large descriptive and insufficient or inconsistent information was given on both the *Atoh1* transfection and Notch inhibition experiments, making it difficult for the readers to interpret the results and make meaning conclusion.

First, it is unclear how variably healthy the tissues are when first harvested, as no hair cell counts, or low/mag high magnification pictures were given. A previous study from this group (Taylor et al., 2015) has characterized missing hair cells and occasion hair cells with damaged stereocilia, and such variable composition (hair cell number, supporting cell number, and hair cells missing stereociliary bundle) can likely affect the final results of the experiments. For instance, hair cells without bundles may survive aminoglycoside treatment and can be directly transfected and re-grow stereocilia (Yang et al., 2012). Also, given the substantial size of the human utricle, hair cell counts from 2000 microns also seem inadequate. It would be important for the authors to reason the quantification method and describe how those areas chosen can reasonably represent the whole sensory epithelium. Also, are striolar vs extrastriolar regions separately analyzed?

Secondly, the efficiency of transfection will need to be more thoroughly described. At present, only high mag pictures showing some transfected supporting cells are shown in Figure 3. Are there any hair cells transfected early on to suggest that surviving hair cells were transfected? What is the extent of *Atoh1* expression and degree of colocalization with GFP+ cells? Right now, only 2 GFP cells are shown in the utricle and one expresses *Atoh1*. Figure 3D describes the crista, but epithelium appears flat isn\'t shaped convex as in the crista. Again, more thorough quantification with low mag picture to go with the high mag pictures would be essential. Similarly, it is unclear how TAPI-treated tissues are quantitatively analyzed, as no pictures were shown, and only small areas were reportedly analyzed. How was the dose of TAPI chosen? How does the author decide that is the optimal dose for human utricles? The authors also discussed the use of DAPT (they said DAPI) and LY411575 and found no definitely effects. Thus, it is difficult to determine if Notch inhibition (or when combined with *Atoh1*) is less effective in inducing new hair cells or not.

With regards to SEM and TEM analyses in Figure 5, it is unclear how the authors determine that the pictures represent the GFP-transfected cells without co-labeling. As stated earlier, the information on the rate and cell types transfected and also health of harvested tissues will help the readers determine the meaning of these TEM and SEM analyses.

Lastly, the RNAseq experiments will benefit from further validation of genes up- and downregulated.

Reviewer \#3:

This is an important paper that provides evidence for regeneration of hair cells in the vestibular epithelium in aged human tissue. This reviewer appreciates the rarity of being able to analyse such tissue and the authors have done an excellent job in getting the most out of this valuable tissue.

Discussion section: \"the generated cells are sometimes seeming in contact with each other\" Do the authors have any transmission electron microscopy data? If so, it would be good to include it, but of course, it is not necessary to do new experiments. Are the authors suggesting here that the newly generated cells are derived from a single clone?

Subsection "Quantification": For the cell counts, can the authors identify which region of the utricular macula the counts were taken? It would make a difference whether the analysis was done in the striolar (central) region versus the extrastriolar (peripheral) region, as the striolar region is damaged first and develops first during normal development. I think this would be an important thing to analyse if the confocal stacks can still be visualised.

Figure 6B: This reviewer is not certain that the apoptotic body is inside a supporting cell, not unless the supporting cell is also dying. The cytoplasm of the cell in question, although it appears to be touching the basement membrane, is much lighter than the surrounding cells, which are indeed supporting cells, as one can tell by the presence of secretory granules within their cytoplasm and their more clumped heterochromatin. Although it seems unlikely that one hair cell would endocytose another, stranger things have happened during cell death.

Figure 6F: Are the rod-like inclusions the same as what have been termed \"cytocauds\"? Can the authors speculate upon whether these are re-absorbed hair bundles?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Regenerating hair cells in human vestibular sensory epithelia\" for further consideration at *eLife*. Your revised article has been evaluated by Andrew King (Senior Editor), Tanya Whitfield (Reviewing Editor), and one reviewer.

We felt that you had addressed comments from reviewers 1 and 3 satisfactorily, but reviewer 2 had asked for further validation of your RNAseq data. In your response, you stated that this had been \'clarified\'. However, this did not actually seem to have been addressed anywhere. Suitable experiments would include qPCR and/or in situ hybridisation or immunohistochemistry for a selection of the genes that you have identified via RNASeq as up- or down-regulated after *ATOH1* mis-expression. This additional validation was listed as an essential revision in the initial decision letter, and this requirement still stands. Please see the detailed comments from the reviewer below.

Reviewer \#2:

The authors have done a decent job addressing the reviewers\' concerns to improve the candidacy of this manuscript. Specifically, the methods used to quantify hair cells and the variability of hair cell number are described and the use of a supratherapeutic dose of aminoglycoside to ablate \"all\" hair cells explained. However, it is still somewhat perplexing that authors think that hair cells without bundles can take up aminoglycosides and be ablated.

Nonetheless, more convincing pictures of ATOH1-GFP, Myosin7+ hair cells were shown, indicating that supporting cells are competent. However, Figure 3D still shows that both actin and DAPI in blue (I think this is a typo). Lastly, it is stated that RNAseq experiment results should be validated, this was not addressed even though the author states \"clarified\". Since mechanism of *Atoh1* can be viewed as a strength of this paper, validation of these data will help its candidacy.

10.7554/eLife.34817.016

Author response

> Reviewer \#1:

*\[...\] 1) The first question is on the viability of the hair cells* in vitro*, and the basal conditions on which the lesion/regeneration model is compared with. In subsection "Untreated utricles" one reads \"Hair cells survived* in vitro *in untreated samples maintained in explant culture for up to 21 days\", but also \"Condensed, misshapen remnants of dying cells also immunolabelled positively for myosin VIIa\". The second sentence reveals that the culture conditions are suboptimal and progressively cause hair cell death, thus denying the first sentence.*

The point we are making is that it is possible to maintain the tissue in good condition for up to ca. 28 days at which point sometimes there are indications in some cultures of incipient degeneration. This provides the time scale for the incubation periods to be used subsequently (21-22 days) to explore regenerative potential.

Amended to say:

"Hair cells survived in vitro in most untreated samples maintained in explant culture for 28 days although in some cultures maintained for this time, condensed, misshapen remnants also labelled positively for myosin VIIa suggesting a possible incipient deterioration in the cultures by this time (Figure 1D). This defined a period of 21-22 days for an optimal total time of incubation in subsequent experiments, a period of sufficient length to cover that over which spontaneous regeneration of hair cells occurs in the vestibular organs in vivo in guinea pigs (Forge et al. 1993,1998), chinchillas (Lopez et al. 1997) and mice (Kawamoto et al., 2009)."

> Therefore, to allow for a good appraisal of the damage and regeneration capacities of the utricles in the model, the article should include data of hair cell density in the cultures before gentamicin treatment, and in untreated utricles after 18-20 days in culture. A fair estimation of these densities should be possible retrospectively from stored images of the experiments reported, or from ongoing experiments. Otherwise, this aspect should be discussed.

There was no intention to make comparisons directly between the tissue before treatment to ablate hair cells and that after the application of a potential regenerative procedure, nor between that condition and the number of hair cells that would have been present if no ablation had occurred. We have tried to clarify this in what we have added in the Discussion section, which hopefully has removed any misunderstanding as to the comparisons being made.

We now add in the opening paragraph of the Discussion section:

"The objective of the study was to determine whether supporting cells can be induced to generate cells with hair-cell like features \[we have also included a phrase in the last paragraph of the Introduction to emphasise this\]. As we illustrated in our previous paper the number of hair cells in the vestibular sensory epithelia of humans may vary widely mainly due to ageing (and genetic variations that likely affect how susceptible to the effects of ageing different individuals might be). Consequently, the initial goal was to try to ablate as many hair cells as possible to create conditions that were essentially the same for all samples, with almost no hair cells present to create an epithelium composed predominantly of supporting cells. This was the starting point to test the capacities of supporting cells and also to remove possible confounds presented by any remaining hair cells. This condition also would mimic something similar to what we and others (Wright, 1983) have shown to be the situation in the vestibular sensory epithelia of elderly people who might be the ones to benefit from a regenerative strategy were one available. The prolonged (48h), high dose (2mM) gentamicin treatment we used was designed to achieve this condition and the results indicate that this was largely accomplished".

> 2\) The presence of elongated microvilli (Figure 5A) in damaged utricles treated with ATOH1 is shown. However, their absence (or smaller presence) in damaged untreated utricles or in non-damaged utricles is not shown. The authors must have this evidence to support their conclusion.

An additional panel has been added to Figure 2 panel I to illustrate the absence of cell surface projections and is referred to in the text:

"The cell surfaces of almost all cells across the epithelium were of similar appearance (Figure 2I), with no surface projections or other structural specialisations, except for dispersed short microvilli, and with a polygonal outline, features characteristic of supporting cells following loss of hair cells."

> 3\) The MYO7A+ data are analyzed by multiple t-test of damaged+treated groups versus a common single damaged-untreated group. The data should instead be analyzed by one-way ANOVA followed by an appropriate post-hoc test for multiple comparisons.

We are aware that ANOVA is the appropriate test for multiple pairwise comparisons. We did not use the t-tests for this purpose and we did not comment upon significance levels between the three different treatment groups. Our initial aim was to determine whether any of the individual treatment conditions produced a significant difference from the control (hair cells ablated, no subsequent treatment, tissue maintained for a prolonged period post hair cell ablation). Each treatment condition is independent of the others and therefore the comparisons are discrete and used to discover treatments that induced hair cell generation from supporting cells. We believe independent t-tests are appropriate for such analysis and advice from others with statistical expertise confirmed this. Nevertheless, we did also perform an ANOVA with Tukey correction. This showed additionally that there is no significant difference between the ATOH1 alone and ATOH1+TAPI conditions; i.e. combining treatments does not enhance the ATOH1-induced generation the MyoVIIa +ve cells, a conclusion it was possible to draw from the means presented in the text and the box plots presented in figure 4. ANOVA also showed a significant difference between ATOH1 transduction and TAPI1 treatment. Essentially this also is evident from the box plots. In the text, for clarity and brevity, we did not mention significance levels between treatment groups, but have now included them in the text.

> 4\) The age of the donors in each group must be shown and compared, to eliminate the possibility that the observed differences among groups are due to age differences.

The mean ages and the age ranges for each group are included in the text. There are no significant differences between groups in the ages of the donors of the samples. We have added in the text:

"There was no significant difference in the mean ages of the donors in each treatment group and the age ranges were similar (control: mean 58.1, range 36-81; ATOH1 transduced: mean 55.7, range 41-67; TAPI1: mean 46.8, range 32-64; ATOH1+TAPI: mean 46.7; range 20-71). This indicated that age is unlikely to be a factor underlying the difference between treatment regimes in the in the number of myosin VIIa cells generated".

However, we would note that we see no reason why age should have an effect on the capacity of supporting cells to respond to signals. We now discuss this in the Discussion section which also addresses the question of the health of the tissue.

"In our work, we made no distinction between samples on the basis of age, but it has been suggested that age may influence the ability of supporting cells to regenerate lost hair cells. In mammals, a capacity of post-mitotic supporting cells in immature early postnatal (mouse) tissue to respond to regenerative signals or to generate new hair cells is dramatically reduced in the mature tissue of pre-weaner juveniles or young adults (Burns and Stone, 2017; Gu et al., 2007). \[...\] Interestingly, it has been suggested that in birds, the capacity to regenerate hair cells from the supporting cell population continues unabated throughout life (Krumm et al., 2017)."

> In fact, the image in Figure 1A shows a density of hair cells much lower than that expected in young adult mammals, suggesting that this utricle suffers hair cell loss, probably related to the age of the donor (Taylor et al., 2015). May this explain the unexpected finding that ATOH1+TAPI-1 utricles showed less MYO7A+ cells than the ATOH1 alone utricles?

The means and range of ages for the individuals in each treatment group are included in the text in the Results section:

"There was no significant difference in the mean ages of the donors in each treatment group and the age ranges were similar (control: mean 59.7, range 45-81; ATOH1 transduced: mean 55.3, range 41-66; TAPI1: mean 46.6, range 32-57; ATOH1+TAPI: mean 46.7; range 20-71). This indicated that age is unlikely to be a factor underlying the difference between treatment regimes in the in the number of myosin VIIa cells generated".

There are no significant differences between the groups in the ages of the tissues donors, but it should be noted as pointed out above that the prolonged (48h), high dose (2mM) gentamicin treatment we used was designed to ablate as many hair cells as possible, to obtain as far as practicable a uniform starting point of a predominantly supporting cell population for all samples to be tested for regenerative potential. In this context, we believe the hair cell number in the tissue when first harvested is not really relevant to the study.

> Reviewer \#2:
>
> The submitted manuscript by Forge\'s research group characterizes the response of Atoh1 gene transfer into the cultured human utricles. This is an important topic because there are very few studies describing how the human inner ear regenerates in response to manipulation. Overall, the study is large descriptive and insufficient or inconsistent information was given on both the Atoh1 transfection and Notch inhibition experiments, making it difficult for the readers to interpret the results and make meaning conclusion.
>
> First, it is unclear how variably healthy the tissues are when first harvested, as no hair cell counts, or low/mag high magnification pictures were given.

We are not clear what is meant by "healthy", but the suggestion would seem to be that it is based on hair cell numbers. We performed a quality control as best as was possible when harvested tissue arrived in the laboratory to ensure that there was intact epithelium and to assess its quality. About half the samples did not meet a series of criteria and were rejected (We refer to this in the text). As we also state in our earlier paper (Taylor et al., 2015), to which reference is made, some samples, taken at random, were exposed to the dye FM1-43, which is taken up by viable hair cells, to identify whether viable hair cells were present. But also, as we point out in answer to reviewer 1 above, the important criterion is the health of the supporting cells. Hair cell number is no indicator of this; was highly variable between samples; and, as we point out in response to reviewer 1 we tried to and appeared to succeed in ablating almost all hair cells before we initiated examination of potential regenerative regimes. We therefore feel the number of hair cells present at the outset is not really relevant.

But as we again point out in the response to reviewer 1 above and have now included in the Discussion section of the present paper, there are certain criteria by which it is possible to judge that the supporting cells in most of the cultures were healthy even when obtained from elderly donors and/or maintained ex vivo for prolonged periods.

> A previous study from this group (Taylor et al., 2015) has characterized missing hair cells and occasion hair cells with damaged stereocilia, and such variable composition (hair cell number, supporting cell number, and hair cells missing stereociliary bundle) can likely affect the final results of the experiments. For instance, hair cells without bundles may survive aminoglycoside treatment and can be directly transfected and re-grow stereocilia (Yang et al., 2012).

We also showed in that earlier paper that FM1-43 was taken up into hair cells in samples which subsequent SEM showed had lost hair bundles from most of the hair cells. FM1-43 is taken up into viable hair cells and thus, such uptake is a measure of hair cell viability. The dye is also used increasingly as a surrogate for aminoglycoside in studies of drug uptake as it enters hair cells via the transduction channel as do aminoglycosides; if FM1-43 enters the cell, then aminoglycoside uptake is likely. Thus, our previous observations would suggest that aminoglycosides can enter hair cells even when the hair bundle is lost. In the present work, as pointed out above in response to reviewer 1, we used a high concentration of gentamicin for a prolonged period to try to ensure that almost all hair cells were ablated -- which the results show was achieved.

While the study by Yang et al., and others, have shown that there may be a potential for sub-lethally damaged hair cells to lose hair bundles and re-grow them, in most of those cases where this has been examined in mammals, including the study by Yang et al., the hair cells are retained at the surface of the epithelium and are easily distinguished from supporting cells by their smooth and defined, approximately rounded apical surfaces. In our previous paper we showed this to be the case for hair cells that had lost their hair bundles, were not exposed to gentamicin in culture, and were maintained for up to 4 weeks after harvesting. The absence of these distinctive hair cell surface features in the gentamicin treated tissue in the present work is evident in the newly added Figure 2I. Furthermore, in the study by Yang et al., and other papers where repair has been suggested, the "repaired" hair bundles show characteristic hair bundle morphologies, which, as we point out, we have never seen in the studies described in this paper. In addition, when counting cell bodies labelled for myosin VIIa as a measure of hair cell numbers, care was taken to assess the entire depth of the epithelium so that any hair cell bodies enclosed with the corpus of the epithelium, would be included, but the counts showed that the majority of hair cells were ablated by the gentamicin treatment protocol. These observations suggest few if any of the original hair cells would have been transduced and contributed to the population numbers of myosin VIIa labelled cells following transduction.

> Also, given the substantial size of the human utricle, hair cell counts from 2000 microns also seem inadequate. It would be important for the authors to reason the quantification method and describe how those areas chosen can reasonably represent the whole sensory epithelium.

The reviewer draws attention to an error. The hair cell counts quoted and used in analysis are normalised for a unit area of 10,000µm^2^. This has been corrected throughout. We try to clarify the procedure used with amendments to the text in the Materials and methods section.

"Assessment was made of at least two different fields on a single utricle viewed with a x20 objective, with a random movement in X and Y planes between each field. In each field intact Myo VIIa positive cells with a distinct nucleus were counted in a delineated, measured area of at least 20,000µm^2^ enclosing continuous intact epithelium as defined by phalloidin labelling of cell-cell junctions at the luminal surface, and excluding regions where the epithelium was folded over on itself, or was significantly disrupted, which occurred in several samples during prolonged incubation and processing due to the friability of the tissue and detachment of the epithelium from the underlying mesenchyme. At each location, each individual optical section through the entire depth of the epithelium was analysed. Cell counts were normalised to a unit area of 10000µm^2^."

> Also, are striolar vs extrastriolar regions separately analyzed?

We did not distinguish between striolar and extrastriolar regions especially as it was difficult to define these regions after the hair cell loss. As the figures (and hair cell counts) illustrate, most hair cells were ablated and thus it was difficult to locate the striola by a region of hair bundle polarity reversal, and the cells that were generated did not form polarised bundles so there was no line of polarity reversal to define.

> Secondly, the efficiency of transfection will need to be more thoroughly described. At present, only high mag pictures showing some transfected supporting cells are shown in Figure 3. Are there any hair cells transfected early on to suggest that surviving hair cells were transfected?

It is likely that if there were surviving, intact hair cells they would be transduced. We have no evidence for this occurrence, but as we show almost all hair cells -- cells that labelled for myosin VIIa -- surviving at the end of the period of incubation with gentamicin showed features indicating a terminal pathology, most notably the internalised actin bundle that has been suggested to be a structure associated with imminent phagocytosis by supporting cells (Bucks et al., 2017). The number of such cells was small as our reported hair cell counts show and thus, if they survived for the entire period post-transduction are unlikely to have contributed greatly to the outcome.

> What is the extent of Atoh1 expression and degree of colocalization with GFP+ cells? Right now, only 2 GFP cells are shown in the utricle and one expresses Atoh1. Figure 3D describes the crista, but epithelium appears flat isn\'t shaped convex as in the crista. Again, more thorough quantification with low mag picture to go with the high mag pictures would be essential.

The images shown are from frozen sections (as now note in the legend to Figure 2), with which, in our hands, we find immunolabelling for ATOH1 to be more reliable than with whole mounts, possibly because of the need use signal amplification protocols (as described in the Materials and methods section) for detection of the labelling. Unfortunately, this made quantification difficult. However, the transcriptomic analysis shows that at 5 days after transduction there is a highly significant expression level of *ATOH1* as already stated in the text.

The image of the crista has been presented at 90° to the long axis to be consistent with orientation of other utricular maculae for the benefit of readers who are not familiar with the morphology of cristae.

> Similarly, it is unclear how TAPI-treated tissues are quantitatively analyzed, as no pictures were shown, and only small areas were reportedly analyzed.

The TAPI 1 samples were analysed in the same way as the ATOH1 transduced samples. We did not include a figure as it provides no more information than the number of myosin VIIa +ve cells that is given in the text and Figure 4.

> How was the dose of TAPI chosen? How does the author decide that is the optimal dose for human utricles? The authors also discussed the use of DAPT (they said DAPI) and LY411575 and found no definitely effects. Thus, it is difficult to determine if Notch inhibition (or when combined with Atoh1) is less effective in inducing new hair cells or not.

The doses used are those reported in the paper by Lin et al., 2011 as we now mention in the Discussion section. We agree that we cannot be sure that Notch inhibition is less effective. We have added in the Discussion section:

"It may also be that higher concentrations of agents that inhibit the Notch pathway are required in the human tissue than in mouse and this may warrant further investigation".

DAPI now corrected to DAPT.

> With regards to SEM and TEM analyses in Figure 5, it is unclear how the authors determine that the pictures represent the GFP-transfected cells without co-labeling. As stated earlier, the information on the rate and cell types transfected and also health of harvested tissues will help the readers determine the meaning of these TEM and SEM analyses.

The reviewer is correct that SEM and TEM analyses do not directly show that cells are myosin VIIa +ve and that we would need to perform immunogold labelling to show this. We are working on that. We do not state specifically that the particular cells shown in EM images are transduced cells expressing GFP. What we say is that in tissue that had been transduced, SEM shows numerous cells that bear clusters of microvilli which are not seen in control tissue (figure now included Figure 2I), At the very least this observation shows that ATOH1 transduction induced some kind of phenotypic alteration to supporting cells. Furthermore, transduced immunolabelled tissue examined as whole mounts showed cells with clusters of microvilli the same as those seen by SEM were GFP+ve and myosin VIIa +ve (Figure 5E). Additionally, when after confocal examination of individual samples of the immunolabelled tissue, those same samples were subsequently prepared for and examined by SEM, numerous cells bearing clusters of microvilli were evident. Likewise, when samples examined by SEM that showed numerous cells bearing clusters of microvilli were subsequently prepared for thin sections and examined by TEM, distinct cells that bore clusters of elongated microvilli showed features reminiscent of hair cells. Taken together it would seem to be reasonable to infer that the transduction led to the generation of cells with clusters of microvilli that had some morphological features consistent with that of hair cells.

> Lastly, the RNAseq experiments will benefit from further validation of genes up- and downregulated.

Clarified.

> Reviewer \#3:
>
> This is an important paper that provides evidence for regeneration of hair cells in the vestibular epithelium in aged human tissue. This reviewer appreciates the rarity of being able to analyse such tissue and the authors have done an excellent job in getting the most out of this valuable tissue.
>
> Discussion section: \"the generated cells are sometimes seeming in contact with each other\" Do the authors have any transmission electron microscopy data? If so, it would be good to include it, but of course, it is not necessary to do new experiments.

We do not have any TEM images of cells with hair cell-like features contacting each other.

> Are the authors suggesting here that the newly-generated cells are derived from a single clone?

No. The point we were making here, to which we refer in the final paragraph of the Discussion section, is that while cells with some hair-cell like feature were generated, the normal regular mosaic whereby each hair cell is separated from its neighbours by intervening supporting cells is not re-created. This may have functional implications.

> Subsection "Quantification": For the cell counts, can the authors identify which region of the utricular macula the counts were taken? It would make a difference whether the analysis was done in the striolar (central) region versus the extrastriolar (peripheral) region, as the striolar region is damaged first and develops first during normal development. I think this would be an important thing to analyse if the confocal stacks can still be visualised.

See response to reviewer 1.

> Figure 6B: This reviewer is not certain that the apoptotic body is inside a supporting cell, not unless the supporting cell is also dying. The cytoplasm of the cell in question, although it appears to be touching the basement membrane, is much lighter than the surrounding cells, which are indeed supporting cells, as one can tell by the presence of secretory granules within their cytoplasm and their more clumped heterochromatin. Although it seems unlikely that one hair cell would endocytose another, stranger things have happened during cell death.

This is Figure 2B. We have replaced the original panel with an alternative from another sample which shows the same things and hopefully is less contentious.

> Figure 6F: Are the rod-like inclusions the same as what have been termed \"cytocauds\"? Can the authors speculate upon whether these are re-absorbed hair bundles?

This is Figure 2F In the text we already state:

"The hair cell bodies that persisted for up to 8 days after gentamicin exposure \[...\] were always rounded in shape and most contained an actin-rich rod-like inclusion structure (Figure 2E, F, G) indicative of pathology being reminiscent of a cytocaud observed in damaged guinea pig vestibular hair cells (Kanzaki et al., 2002), and in mice appearing in damaged hair cells destined for phagocytosis by supporting cells (Bucks et al., 2017)".

The latter paper suggests that these actin inclusions somehow play a role in the active uptake of the damaged hair cell by the supporting cell. Thus, they may be an indication of a dying hair cell destined for removal. We do not know their origin, but they do label for the stereociliary protein espin, though we have not mentioned this in the paper, as we do not believe it is directly relevant to the theme of this paper.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> We felt that you had addressed comments from reviewers 1 and 3 satisfactorily, but reviewer 2 had asked for further validation of your RNAseq data. In your response, you stated that this had been \'clarified\'. However, this did not actually seem to have been addressed anywhere. Suitable experiments would include qPCR and/or in situ hybridisation or immunohistochemistry for a selection of the genes that you have identified via RNASeq as up- or down-regulated after ATOH1 mis-expression. This additional validation was listed as an essential revision in the initial decision letter, and this requirement still stands. Please see the detailed comments from the reviewer below.
>
> Reviewer \#2:
>
> The authors have done a decent job addressing the reviewers\' concerns to improve the candidacy of this manuscript. Specifically, the methods used to quantify hair cells and the variability of hair cell number are described and the use of a supratherapeutic dose of aminoglycoside to ablate \"all\" hair cells explained. However, it is still somewhat perplexing that authors think that hair cells without bundles can take up aminoglycosides and be ablated.
>
> Nonetheless, more convincing pictures of Atoh1-GFP, Myosin7+ hair cells were shown, indicating that supporting cells are competent.

We are pleased that we have addressed satisfactorily the comments from reviewers 1 and 3 and "have done a decent job addressing \[most of reviewer \#2's\'\] concerns to improve the candidacy of this manuscript". However, reviewer \#2 and the editors both ask for some means to "validate" the RNA sequencing data as an essential revision. In line with the editors' suggestions that "suitable experiments would include qPCR \[...\] for a selection of the genes \[...\] identified via RNASeq as up- or down-regulated after ATOH1 mis-expression", we have now performed such experiments. These have confirmed the same change in direction and similar expression level for 5 genes -- listed in Table 1 in the paper- that RNA-sequencing showed to be either up (3 genes) or down (2 genes) regulated after transduction with ATOH1. We have amended the text accordingly.

In subsection "Gene expression changes with Ad2-ATOH1-GFP transduction":

"To validate results from the RNA-sequencing, quantitative RT-PCR was conducted on five of the genes listed in Table 1. These were CITED, IRF9, SNAI1, EP300 and HDAC9. In all cases the trends for fold-changes were the same as in RNA-seq and in most cases they were very close in actual values (Figure 6)."

We have added the data from that analysis as an additional figure (Figure 6).

And in subsection "Quantitative RT-PCR":

"Taqman assays for CITED, IRF9, SNAI1, EP300 and HDAC9 (Hs 00388363, Hs00196051, Hs00195591, Hs00914223 and Hs^-1^081558) were purchased from ABI and were run in technical triplicates on an ABI QuantStudio Real Time PCR System under manufacturer's standard parameters for comparative C~T~ analysis. Total polyA+ RNA from two ATOH1 utricle transduction experiments (5 days post gentamicin) were separately converted into cDNA. These were then pooled and constituted the ATOH samples. Total polyA+ RNA from three control utricle samples (2 days, 8 days and 14 days post gentamicin) were separately converted into cDNA. These were then pooled and constituted the control samples. Amplifications were normalized to a GAPDH internal control (ABI Taqman assay Hs99999905)."

> However, Figure 3D still shows that both actin and DAPI in blue (I think this is a typo). Lastly, it is stated that RNAseq experiment results should be validated, this was not addressed even though the author states \"clarified\". Since mechanism of Atoh1 can be viewed as a strength of this paper, validation of these data will help its candidacy.

This is not a typo. Both labelling of actin with fluorescently-tagged phalloidin and DAPI labelling of nuclei are in the blue channel. The labelling for actin is shown to provide orientation and to show the integrity of the tissue. The legend has been amended to include:

"Phalloidin-labelled actin, as well as DAPI to label nuclei, is in the blue channel to label the intercellular junctions as orientation for identification of the luminal surface of the epithelium".

We hope we have now addressed satisfactorily all the outstanding concerns of reviewers and editors and that you will now find the paper acceptable for publication in *eLife*.
